Additional information
| Dosage Form | Tablets |
|---|---|
| Specialities | Diabetologist, Physician |
| Packing | 1 x 10 (Blister) |
| Therapeutic Segment | Anti-diabetic |
Gliclazide stimulates insulin secretion through the beta cell sulphonylurea receptor, and possibly through a direct effect on intracellular calcium transport. It specifically improves the abnormal first phase insulin release in type 2 diabetes, and also has an effect on the second phase.
As directed by physician
